Rhythm control agents and adverse events in patients with atrial fibrillation.
BACKGROUND: Atrial fibrillation (AF) is the commonest rhythm disorder and has major impact on patients. Controversy remains about the best treatment strategy between rate and rhythm control (in addition to adequate thromboprophylaxis). Rhythm control agents are associated with clinically important...
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Journal article |
| Språk: | English |
| Publicerad: |
2010
|